The Alzheimer’s Association — a Chicago-based nonprofit committed to Alzheimer’s research, care and support — shared its top ...

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

The Alzheimer’s epidemic continues to cast a shadow over the lives of millions. This disease erodes memories and cognitive ...

What if the solution to Alzheimer’s disease lies not in combating the proteins that cause it, but in simply getting more ...

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

In a year plagued by the challenges of Alzheimer's disease, 2024 brought a glimmer of hope with the approval of the third new ...

Spread the loveA new Alzheimer’s treatment has shown unprecedented success in late-stage clinical trials, offering hope to ...

A team of exceptional researchers are applying free-market principles in their efforts to tackle the devastating disease ...

Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...

“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year ...

Using these measures will assist in reducing the fall risk in persons with Alzheimer’s, but there is no guarantee. Daily ...

A promising ultrasound therapy to potentially restore brain function in people with Alzheimer's disease has been licenced to ...